OPUS 4 | Search

3 search hits

1 to 3

Sort by

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021)

A German-wide systematic study on mobilization and collection of hematopoietic stem cells in poor mobilizer patients with multiple myeloma prior to autologous stem cell transplantation (2023)

Mobilization and hematopoietic stem cell collection in poor mobilizing patients with lymphoma: final results of the german OPTIMOB study (2023)

1 to 3